Fifth Edition of the Global Health Cast presented by Prof. Schmitt and Dr. Sanicas. Topics Covered: 00:00 Introduction 00:42 COVID-19 update and news 10:25 Can bio-scans measure body oscillations predicting health risks...
Topics Covered: 00:00 – Introduction 00:55 – Global COVID-19 situation: cases continue to decline 05:26 – AZD7442 – mAB for prevention of COVID-19 09:12 – Lack of Immune response to SARS-CoV2 in...
Inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays, McMaster scientists who compared respiratory vaccine-delivery systems have confirmed. While nasal sprays reach primarily...
COVID-19 vaccination provides a foundation of protection that’s enhanced by breakthrough infection; ‘the key is to get vaccinated’ Breakthrough infections greatly enhance immune response to variants of the virus that...
Faced with short supplies of COVID-19 vaccines and unforeseen side effects, some countries have adopted an unproven strategy: switching shots midstream. Most authorized vaccines require two doses administered weeks or...
Whether we would develop immunity to COVID-19, or how long that would last if we did, has been a mystery since the early months of the pandemic. However, two new studies are helping us better understand how our immune...
For a world crippled by the coronavirus, salvation hinges on a vaccine. But in the United States, where at least 4.6 million people have been infected and nearly 155,000 have died, the promise of that vaccine is...
Sinovac Biotech announced preliminary study results. showing its experimental Covid-19 vaccine generated immune responses in patients and was safe — early data that suggest it might protect people against infections...
The vaccine rVSV-EBOV is currently used in the fight against Ebola virus. Since 2018, more than 200,000 people have been vaccinated. However, how the vaccine actually works was only partially known. The research team...
An experimental vaccine against respiratory syncytial virus (RSV), one of the leading causes of infectious disease deaths in infants, has shown early promise in a Phase 1 human clinical trial. A team of researchers...